A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis
Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, March 2016
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (68th percentile)
Readers on
- mendeley
- 115 Mendeley